1. Home
  2. CTSO vs VTGN Comparison

CTSO vs VTGN Comparison

Compare CTSO & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.46

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.69

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
VTGN
Founded
1997
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
24.1M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
CTSO
VTGN
Price
$0.46
$0.69
Analyst Decision
Buy
Hold
Analyst Count
2
3
Target Price
$5.38
$0.90
AVG Volume (30 Days)
209.1K
820.6K
Earning Date
05-01-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
$124.49
Revenue Next Year
$22.41
$353.99
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.37
$0.43
52 Week High
$1.39
$5.14

Technical Indicators

Market Signals
Indicator
CTSO
VTGN
Relative Strength Index (RSI) 45.56 64.14
Support Level $0.37 $0.54
Resistance Level $0.72 $0.77
Average True Range (ATR) 0.06 0.06
MACD 0.01 0.01
Stochastic Oscillator 35.57 79.43

Price Performance

Historical Comparison
CTSO
VTGN

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: